TCRX
TScan TherapeuticsFNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
Operating peers and competitors
Source-backed product markets and frozen research comparisons. Valuation comparators remain in the existing peer table.
Loading market evidence...
Research comparisons do not establish forecast usefulness or trading returns.
Compare shared product markets
Membership only; no portfolio weights or estimated losses.
+
Peers tracked
8
U.S. public peers
Grade Position
Below peers
vs peer average
TCRX vs peer average
24/100
TCRX vs. peer average (F vs. C)
Grade spread
A 2 · B 1 · D 2 · F 3
Graded peers loaded
Coverage
8 graded
100% of tracked
Peer overview
LPCN is the first available peer comparator.
Same sector: Pharmaceuticals, Biotechnology & Life Sciences · Cap $11.87M
✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
TCRX
TScan Therapeutics
LPCN
Lipocine
Grade
F
A
Momentum
10
100
Value
41
57
Sentiment
-
69
Setup Bias
Net —
-
Market Cap
-
-
Posture
Defensive
Constructive
Grade position vs LPCN
TCRX / LPCN
Grade Position
Below peers
TCRX vs. peer average (F vs. C)
24/100
Momentum
10
LPCNValue
41
LPCNSentiment
-
-Rotation landscape
Peers ranked by the order returned from the peer source, with grades from the API.
Rank
Ticker
Company
Grade
Grade score
vs TCRX
LPCN is the first peer returned for this comparison set.